Specifically, these findings linked VAT to the upregulation of CD36, a scavenger receptor and FA-translocase well-established in cardiovascular disease progression [23], as an upstream event driving the dysfunction of Kir2.1 in obesity [27]. The gene discussed is CD36; the disease is obesity disorder.